TY - CHAP M1 - Book, Section TI - Introduction to Biopharmaceutics and Pharmacokinetics A1 - Shargel, Leon A1 - Ducharme, Murray P. A2 - Ducharme, Murray P. A2 - Shargel, Leon PY - 2022 T2 - Shargel and Yu's Applied Biopharmaceutics and Pharmacokinetics, 8e AB - Define biopharmaceutics and pharmacokinetics.Define drug product performance and discuss how biopharmaceutics can affect drug product performance.Describe how pharmacokinetic studies relate to clinical efficacy and drug toxicity.Discuss how clinical pharmacokinetics is used to develop drug dosage regimens in patients.Define a pharmacokinetic model and the assumptions that are used in developing a pharmacokinetic model.Discuss how the prescribing information or approved labeling for a drug helps the practitioner to recommend an appropriate dosage regimen for a patient. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - accesspharmacy.mhmedical.com/content.aspx?aid=1188765211 ER -